Bacil Pharma Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Bacil Pharma Ltd is ₹ 55.7 as of 04 May 11:06 . The p/e ratio of Bacil Pharma Ltd changed from 146.5 to 0 over 5 quarters. This represents a CAGR of -100.00% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The market cap of Bacil Pharma Ltd changed from ₹ 60.99 crore to ₹ 8.62 crore over 5 quarters. This represents a CAGR of -79.10% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The revenue of Bacil Pharma Ltd for the Dec '25 is ₹ 0.06 crore as compare to the Sep '25 revenue of ₹ 0.05 crore. This represent the growth of 20% The revenue of Procter & Gamble Health Ltd for the Dec '25 is ₹ 378.22 crore as compare to the Sep '25 revenue of ₹ 329.87 crore. This represent the growth of 14.66% The ebitda of Bacil Pharma Ltd for the Dec '25 is ₹ 0.04 crore as compare to the Sep '25 ebitda of ₹ 0.02 crore. This represent the growth of 100% The ebitda of Procter & Gamble Health Ltd for the Dec '25 is ₹ 114.82 crore as compare to the Sep '25 ebitda of ₹ 125.22 crore. This represent the decline of -8.31% The net profit of Bacil Pharma Ltd changed from ₹ -0.06 crore to ₹ 0.04 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 77.59 crore over 7 quarters. This represents a CAGR of 33.89% The dividend payout of Bacil Pharma Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Bacil Pharma Ltd

Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90.
The main business activity of the Company is Pharmaceutical. Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs.
Domestic operations are spread across pan India.
The company has strong field force of 500 plus, spread over various States and Districts.
It has a strong distribution set up, with Super Stockist in all the States and stockists for retail coverage.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Bacil Pharma Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Bacil Pharma Ltd or Procter & Gamble Health Ltd?

Market cap of Bacil Pharma Ltd is 81 Cr while Market cap of Procter & Gamble Health Ltd is 8,622 Cr

What are the key factors driving the stock performance of Bacil Pharma Ltd and Procter & Gamble Health Ltd?

The stock performance of Bacil Pharma Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bacil Pharma Ltd and Procter & Gamble Health Ltd?

As of May 4, 2026, the Bacil Pharma Ltd stock price is INR ₹56.95. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5194.55.

How do dividend payouts of Bacil Pharma Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Bacil Pharma Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.